Skip to main content
. 2024 Apr 17;2(5):616–626. doi: 10.1038/s44220-024-00240-2

Table 2.

Clinical outcomes included in the systematic review and their corresponding definition/measure of the outcome

Outcome Definition/measure of outcome
ADRs UKU adverse effects score26,27
Symptom severity

SAPS26

PANSS27

CGI-S17,21

Children’s Global Assessment Scale (CGAS)21

Clinicians’ opinions PIP-FQ25
Hospitalizations Overall hospitalization stays per patient23
Medication prescribing

Antipsychotic drug persistence, measured as time in days to the first

modification of the initial antipsychotic treatment (drug or dose

change), to indicate tolerability of medication26

Drug changes26

Dose changes by visual inspection of temporal dose-adjustment

graphs26

Mean daily dose22

Polytherapy through the number of antipsychotics prescribed22